297 related articles for article (PubMed ID: 17338118)
1. [Serum levels of interleukin-6 and interleukin-10 in patients with multiple sclerosis during intravenous immunoglobulin infusion].
Kazibutowska Z; Motta E; Huć M; Strzała-Orzeł M; Woźnik G
Wiad Lek; 2006; 59(9-10):626-9. PubMed ID: 17338118
[TBL] [Abstract][Full Text] [Related]
2. Interleukin 1 components in cicatricial pemphigoid. Role in intravenous immunoglobulin therapy.
Kumari S; Bhol KC; Rehman F; Foster CS; Ahmed AR
Cytokine; 2001 May; 14(4):218-24. PubMed ID: 11448121
[TBL] [Abstract][Full Text] [Related]
3. Pemphigus vulgaris: the role of IL-1 and IL-1 receptor antagonist in pathogenesis and effects of intravenous immunoglobulin on their production.
Bhol KC; Desai A; Kumari S; Colon JE; Ahmed AR
Clin Immunol; 2001 Aug; 100(2):172-80. PubMed ID: 11465946
[TBL] [Abstract][Full Text] [Related]
4. Intravenous immunoglobulin treatment of multiple sclerosis and its animal model, experimental autoimmune encephalomyelitis.
Humle Jorgensen S; Sorensen PS
J Neurol Sci; 2005 Jun; 233(1-2):61-5. PubMed ID: 15949496
[TBL] [Abstract][Full Text] [Related]
5. [Value of serum soluble interleukin-2R, interleukin-6 and C-reactive protein in the early diagnosis of Kawasaki disease].
Peng Q; Wu Q; Chen CH; Hong H; Zhang LY
Zhongguo Dang Dai Er Ke Za Zhi; 2006 Jun; 8(3):208-10. PubMed ID: 16787593
[TBL] [Abstract][Full Text] [Related]
6. Circulating levels of cytokines and their modulation by intravenous immunoglobulin in multifocal motor neuropathy.
Terenghi F; Allaria S; Nobile-Orazio E
J Peripher Nerv Syst; 2006 Mar; 11(1):67-71. PubMed ID: 16519784
[TBL] [Abstract][Full Text] [Related]
7. Treatment of multiple sclerosis with intravenous immunoglobulin: review of clinical trials.
Sørensen PS
Neurol Sci; 2003 Oct; 24 Suppl 4():S227-30. PubMed ID: 14598048
[TBL] [Abstract][Full Text] [Related]
8. Intravenous immunoglobulin in relapsing-remitting multiple sclerosis: a dose-finding trial.
Fazekas F; Lublin FD; Li D; Freedman MS; Hartung HP; Rieckmann P; Sørensen PS; Maas-Enriquez M; Sommerauer B; Hanna K; ;
Neurology; 2008 Jul; 71(4):265-71. PubMed ID: 18645164
[TBL] [Abstract][Full Text] [Related]
9. Serum levels of the pro-inflammatory cytokine interleukin-12 and the anti-inflammatory cytokine interleukin-10 in patients with psoriasis treated by the Goeckerman regimen.
Borska L; Andrys C; Krejsek J; Hamakova K; Kremlacek J; Ettler K; Fiala Z
Int J Dermatol; 2008 Aug; 47(8):800-5. PubMed ID: 18717859
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the immunomodulatory effects of the plant sterol beta-sitosterol to simvastatin in peripheral blood cells from multiple sclerosis patients.
Desai F; Ramanathan M; Fink CS; Wilding GE; Weinstock-Guttman B; Awad AB
Int Immunopharmacol; 2009 Jan; 9(1):153-7. PubMed ID: 19022404
[TBL] [Abstract][Full Text] [Related]
11. Intravenous polyclonal human immunoglobulins in multiple sclerosis.
Soelberg Sorensen P
Neurodegener Dis; 2008; 5(1):8-15. PubMed ID: 18075269
[TBL] [Abstract][Full Text] [Related]
12. Immunomodulatory effects of intravenous immunoglobulins as a treatment for autoimmune diseases, cancer, and recurrent pregnancy loss.
Sapir T; Blank M; Shoenfeld Y
Ann N Y Acad Sci; 2005 Jun; 1051():743-78. PubMed ID: 16127014
[TBL] [Abstract][Full Text] [Related]
13. Intravenous immunoglobulin in primary and secondary chronic progressive multiple sclerosis: a randomized placebo controlled multicentre study.
Pöhlau D; Przuntek H; Sailer M; Bethke F; Koehler J; König N; Heesen C; Späth P; Andresen I
Mult Scler; 2007 Nov; 13(9):1107-17. PubMed ID: 17623736
[TBL] [Abstract][Full Text] [Related]
14. Serum interleukin-6 and interleukin-10 in patients with acute pancreatitis: clinical implications.
Ohmoto K; Yamamoto S
Hepatogastroenterology; 2005; 52(64):990-4. PubMed ID: 16001614
[TBL] [Abstract][Full Text] [Related]
15. High dose intravenous immunoglobulin (IVIG) in dermatomyositis: clinical responses and effect on sIL-2R levels.
Göttfried I; Seeber A; Anegg B; Rieger A; Stingl G; Volc-Platzer B
Eur J Dermatol; 2000; 10(1):29-35. PubMed ID: 10694294
[TBL] [Abstract][Full Text] [Related]
16. Long term safety of IVIg therapy in multiple sclerosis: 10 years experience.
Katz U; Kishner I; Magalashvili D; Shoenfeld Y; Achiron A
Autoimmunity; 2006 Sep; 39(6):513-7. PubMed ID: 17060031
[TBL] [Abstract][Full Text] [Related]
17. Effect of treatment with methylprednisolone on the serum levels of IL-12, IL-10 and CCL2 chemokine in patients with multiple sclerosis in relapse.
Rentzos M; Nikolaou C; Rombos A; Evangelopoulos ME; Kararizou E; Koutsis G; Zoga M; Dimitrakopoulos A; Tsoutsou A; Sfangos C
Clin Neurol Neurosurg; 2008 Dec; 110(10):992-6. PubMed ID: 18657352
[TBL] [Abstract][Full Text] [Related]
18. Stress doses of hydrocortisone in high-risk patients undergoing cardiac surgery: effects on interleukin-6 to interleukin-10 ratio and early outcome.
Weis F; Beiras-Fernandez A; Schelling G; Briegel J; Lang P; Hauer D; Kreth S; Kaufmann I; Lamm P; Kilger E
Crit Care Med; 2009 May; 37(5):1685-90. PubMed ID: 19325469
[TBL] [Abstract][Full Text] [Related]
19. Intravenous immunoglobulin in MS: promise or failure?
Fazekas F; Strasser-Fuchs S; Hommes OR
J Neurol Sci; 2007 Aug; 259(1-2):61-6. PubMed ID: 17449063
[TBL] [Abstract][Full Text] [Related]
20. Influence of intravenous immunoglobulin therapy on serum levels of anti-beta 4 antibodies in ocular cicatricial pemphigoid. A correlation with disease activity. A preliminary study.
Letko E; Bhol K; Foster SC; Ahmed RA
Curr Eye Res; 2000 Aug; 21(2):646-54. PubMed ID: 11148601
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
